Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.50
Bid: 21.00
Ask: 22.00
Change: -2.50 (-10.64%)
Spread: 1.00 (4.762%)
Open: 24.25
High: 21.00
Low: 21.00
Prev. Close: 23.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100

Thu, 04th Jan 2024 12:09

(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak it suffered at the start of the year.

Retailers Next and JD Sports were the best and worst performing blue-chip stocks respectively, after both provided trading updates including the Christmas period.

US stocks were called to open higher, following the release of minutes from the latest Federal Reserve meeting, and before the first of a pair of monthly US employment readings on Thursday.

The FTSE 100 index was up 7.08, or 0.1%, at 7,689.41. The FTSE 250 was up 14.33 points, 0.1%, at 19,340.73, and the AIM All-Share was up 0.28 of a point, marginally up, at 754.34.

The Cboe UK 100 was up 0.1% at 767.56, the Cboe UK 250 was up 0.2% at 16,806.97, and the Cboe Small Companies was up 0.4% at 14,916.62.

The UK service economy had its best performance in six months in December, a strong end to the year which helped boost the wider private sector, numbers showed.

The final S&P Global UK services business activity index climbed to 53.4 points in December from 50.9 in November. This was above the 50.0 no-change mark for the second month running and above the earlier flash estimate of 52.7

The final seasonally adjusted S&P Global UK composite purchasing managers' index registered 52.1 points in December, up from 50.7 in November and above the neutral 50.0 value for the second month running. This beat last month's flash estimate for December of 51.7 points and marked the highest final reading since June.

"The further rebound in December's PMI suggests a recession should be narrowly avoided," said Pantheon Macroeconomics analyst Gabriella Dickens.

In European equities on Thursday, the CAC 40 in Paris was up 0.4%, while the DAX 40 in Frankfurt was up 0.3%.

The eurozone service sector's decline slowed marginally in December, according to survey data from S&P Global.

The latest HCOB services purchasing managers' index posted 48.8 points in December, rising marginally from 48.7 in November and marking the fifth consecutive monthly contraction. The figure remained below the 50-point no-change mark, but registered above the flash estimate of 48.1 points.

S&P Global said demand for services fell at the end of the year, while sales and new business receipts also declined.

The HCOB eurozone composite PMI - a weighted average of the eurozone's manufacturing and services PMIs - posted 47.6 points in December, unchanged from November, and remaining below the 50-point threshold.

Sterling was quoted at USD1.2705 at midday on Thursday, higher than USD1.2646 at the London equities close on Wednesday. The euro traded at USD1.0958, higher than USD1.0915. Against the yen, the dollar was quoted at JPY144.19, up from JPY143.50.

In the FTSE 100, Next rose 4.7%. The retailer said full price sales during November and December were better than it anticipated.

In a trading update covering the nine weeks to December 30, Next said full price sales were up 5.7% from a year earlier, which was GBP39 million than its previous guidance of a 2.0% rise for the period.

Next upped its full-year pretax profit guidance by GBP20 million, or 4.0% to GBP905 million compared to last year, saying GBP17 million of the lift comes from the sales beat to date and GBP3 million from an upgraded forecast for full price sales in January.

JD Sports plunged 23%, after cutting its profit outlook amid weaker-than-expected sales growth and gross margins.

The retailer said organic revenue was up 6.0% in the 22 weeks that ended December 30 on a constant currency basis from a year earlier, with like-for-like growth of 1.8%. This was slightly behind its expectations. The retailer expects organic revenue growth of around 8% for the year ending February 3.

As a result, it expects to report pretax profit and adjusted items of between GBP915 million and GBP935 million for the financial year. This falls short of market expectations of GBP1.04 billion, which back in September, JD Sports had said it expected to meet.

"Our key markets have seen increased promotional activity during the peak trading season, driven by a more cautious consumer, but we continue to grow market share," said JD Sports Chief Executive Officer Regis Schultz.

"We are confident in our strategy and we continue to invest in our supply chain, systems and stores, supported by our strong cash generation and healthy balance sheet."

Oil majors BP and Shell rose 1.8% and 0.9% respectively, tracking higher oil prices. Brent oil bought USD78.87 a barrel early Thursday, higher than USD78.13 on Wednesday, as traders assess latest developments in the Middle East.

"The region remains a tinder box due to the Israel-Gaza war, and disruption to shipping routes through the Red Sea is also a key factor behind the surge in crude," AJ Bell analyst Russ Mould commented.

Among London's small-cap stocks, Topps Tiles lost 7.0%.

The retailer said sales in the 13 weeks ended December 30 were down 4.0% from a year earlier, with like-for-like sales down 7.1%.

It explained that trading in the first quarter reflected the ongoing challenges to discretionary consumer spending, particularly those impacting on businesses serving the repair, maintenance and improvement sector.

Topps Tiles expects its full-year profit to be weighted towards the second half, based on a number of factors including the timing of the holiday pay accrual, higher energy usage in the first half and general trading in the first half.

On AIM, Angle soared 66%, after it unveiled "breakthrough" clinical results from DNA molecular analysis of cancer patient blood samples that "provide a unique insight into the progression of each patient's cancer and how this may be treated".

The medical diagnostics firm said the results "highlight the potential for the Parsortix system to identify key variants [of] DNA mutations missed by other approaches to help guide treatment decisions."

Stocks in New York were called higher. The Dow Jones Industrial Average, the S&P 500 index up and the Nasdaq Composite were all called up 0.2%.

On the US data calendar on Thursday, there is the ADP jobs report at 1315 GMT, a precursor to Friday's nonfarms. The latest initial jobless claims reading is at 1330 GMT, before a services PMI at 1445 GMT.

The data comes after minutes from the Federal Reserve's latest meeting were released overnight.

"Yesterday's FOMC minutes brought a little bit of something for everyone, with members expressing caution as they attempt to drive inflation back down to target. While they currently do not see any upside risk to inflation, there is a concern that they could stall the current disinflation should they pivot too swiftly. Nonetheless, the key takeaway is that they are looking at the six-month metric for the core PCE, which has already dropped below 2%," Scope Markets analyst Joshua Mahony commented.

"With that in mind, markets have remained highly dovish, expecting a whopping six rate cuts this year from the Fed. All eyes will now turn towards the US employment data, with today's ADP payrolls figure leading into tomorrow's jobs report. With Fed member Barkin speculating that a soft-landing looks increasingly likely, a gradual deterioration in the payrolls and unemployment rate could help put pressure on the FOMC to cut rates in March."

Gold was quoted at USD2,047.78 an ounce at midday on Thursday, higher than USD2,038.89 on Wednesday.

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
14 Aug 2020 12:41

Angle's Parsortix Able To Predict Patients' Response To Treatment

Angle's Parsortix Able To Predict Patients' Response To Treatment

Read more
20 Jul 2020 20:03

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

Read more
20 Jul 2020 10:16

Angle's 'Parsortix' advantageous in breast cancer in new research

(Sharecast News) - Angle announced on Monday that the University of Southern California (USC) has published peer-reviewed results of new work undertaken in metastatic breast cancer (MBC), highlighting advantages of a 'Parsortix' liquid biopsy, compared to standard-of-care tissue biopsy.

Read more
25 Jun 2020 12:22

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Read more
18 Jun 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
10 Jun 2020 16:41

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

Read more
12 May 2020 18:54

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Read more
12 May 2020 08:58

Angle upbeat on recent research using 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the liquid biopsy analysis unit at the Health Research Institute of Santiago in Spain has published results of new work undertaken in head and neck cancer and non small cell lung cancer, on the potential utility of a liquid biopsy-based strategy to assess MET alterations on circulating tumour cells (CTCs).

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
28 Apr 2020 10:03

Angle works with skeleton R&D crew during lockdown

(Sharecast News) - Biopharmaceuticals group Angle said on Tuesday that progress had been impeded by the Covid-19 outbreak as the firm worked with a research and development skeleton crew in Guildford.

Read more
31 Mar 2020 12:21

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

Read more
31 Mar 2020 09:40

Angle UK, US, Canada operations 'severely disrupted' by Covid-19

(Sharecast News) - Liquid biopsy company Angle said on Tuesday that operations in the UK, US and Canada had all been "severely disrupted" by the Covid-19 pandemic.

Read more
3 Mar 2020 18:58

Angle Parsortix Test Used To Help Discover Brain Metastasis

Angle Parsortix Test Used To Help Discover Brain Metastasis

Read more
27 Feb 2020 14:09

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Read more
27 Feb 2020 12:42

Angle upbeat on recent Parsortix research out of Italy

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that Istituto Nazionale Tumori di Milano in Milan, Italy, has published results of work assessing the performance of its 'Parsortix' system in renal cell carcinoma (RCC), demonstrating key advantages of Parsortix.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.